33.8℉Washington

Loire-net.tv

  • Health News
  • Family Health
  • Health Problems
  • Kids Health
  • Medications
  • Personal Health
  • Beauty & Balance
Loire-net.tv
  • Health News
  • Family Health
  • Health Problems
  • Kids Health
  • Medications
  • Personal Health
  • Beauty & Balance
  • Home
  • /
  • Health Problems
  • /
  • Targeting stem-like cells could prevent ovarian cancer recurrence

Targeting stem-like cells could prevent ovarian cancer recurrence

Posted on 03/12/2019

Ovarian cancer is not the most common form of cancer, but it’s among the deadliest. That’s because about 70 percent of cases recur. A new study by researchers at the University of Pittsburgh, UPMC Hillman Cancer Center, Magee-Womens Research Institute (MWRI) and several other collaborating institutions targets the root of recurrence with new drugs aimed at annihilating stem-like ovarian cancer cells.

The study, published today in the journal Cell Reports, identifies a new experimental drug, 673A, that specifically kills the stem-like cells that tend to linger after chemotherapy. In a mouse model of ovarian cancer, combined treatment with 673A and chemotherapy resulted in significantly greater survival rates.

“You can think of stem-like cells as seeds. They put down roots and grow into a plant,” said Ronald Buckanovich, M.D., Ph.D., professor of medicine at Pitt, director of the Ovarian Cancer Center of Excellence at MWRI, and co-director of the Women’s Cancer Research Center. “I especially like the dandelion analogy. When we treat cancer, we’re essentially mowing the lawn. But the problem is that dandelions always come back.”

Chemotherapy kills 90 to 99 percent of cancer cells, but because it leaves the stem-like cells behind, the cancer can come back. All it takes is 11 stem-like cancer cells to form a tumor, Buckanovich said. By comparison, it’s possible to transplant 50,000 non-stem-like cancer cells and not get a tumor.

Buckanovich’s drug, 673A, kills these stem-like cells by targeting the ALDH pathway, which the cells rely on to clear the toxins they produce by multiplying so quickly. Treating an ovarian cancer with 673A kills only about 3 to 5 percent of the cells, but since they’re the stem-like cells, that turns out to pack a punch. And, Buckanovich added, it’s not toxic at all to the mice.

In mice that were injected with human ovarian cancer cells, 60 percent of the animals treated with both chemotherapy and 673A were cancer-free six months later, compared to 10 percent of the mice treated with chemotherapy alone.

Even more striking, Buckanovich said, 673A was just as effective against chemotherapy-resistant tumors. When mice injected with these tenacious cells were given 673A in conjunction with chemotherapy, nearly two-thirds of them were in remission six months later. By comparison, all of the mice in the chemotherapy-only group died over this same timeframe.

Since ovarian cancer commonly develops chemotherapy resistance, this new drug has the potential to improve mortality rates for this deadly cancer.

But Buckanovich cautions that more work must done before 673A is ready for market. Right now, it doesn’t last long in the body, and it needs better solubility. It also has yet to be tested in humans. But, more optimistically, he points out that 673A is 10 times as effective at killing stem-like cells than the previous ALDH inhibitor, and its ability to boost the effectiveness of chemotherapy is really encouraging.

Source: Read Full Article

Related posts:
  1. Small-scale poultry farming could mean big problem in developing countries
  2. Lung transplant patients face elevated lung cancer risk
  3. Scientists generate high-quality human vascular cells through genome editing technology
  4. Cancer survivors see mostly positives in how they have changed
Posted in Health ProblemsTagged cancer, cells, could, ovarian, prevent, recurrence, stem-like, Targeting

Post navigation

Exploring hypothalamic circuits, one neuron at a time
Government announces ‘appalling’ 5% price hike of NHS dental treatment
Health Problems
Biden Plan to Lower Medicare Eligibility Age to 60 Faces Hostility From Hospitals
Jan
2021
21

Biden Plan to Lower Medicare Eligibility Age to...

COVID-19 impact on pregnant women focus of NIH grant
Jan
2021
15

COVID-19 impact on pregnant women focus of NIH...

Lifestyle trumps geography in determining makeup of gut microbiome
Apr
2020
01

Lifestyle trumps geography in determining makeup of gut...

Kids Health
On the Anniversary of Kobe Bryant's Helicopter Crash, Christina Mauser Family Still Grieves

On the Anniversary of Kobe Bryant's Helicopter Crash, Christina Mauser Family Still Grieves

The Pandemic Made My Husband a Better Dad

The Pandemic Made My Husband a Better Dad

Health News
Revised WIC food package may aid child development
Jan
2021
25

Revised WIC food package may aid child development

First observation of the early association between proteins linked to Alzheimer’s disease
Jan
2021
25

First observation of the early association between proteins...

Estados permiten contratar profesionales de salud extranjeros por la pandemia
Jan
2021
25

Estados permiten contratar profesionales de salud extranjeros por...

Copyright © 2021 Loire-net.tv. All rights reserved.
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok